A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
- Status
- SUSPENDED
- Phase
- N/A
Clinical Trials Related to Mesothelioma
Related studies linked through entity extraction aliases.
The Registry of Oncology Outcomes Associated with Testing and Treatment
- Status
- COMPLETED
- Phase
- N/A
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma
- Status
- COMPLETED
- Phase
- NA
Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
- Status
- RECRUITING
- Phase
- N/A
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
- Status
- RECRUITING
- Phase
- NA
Dose Individualization of Pemetrexed - IMPROVE-I
- Status
- COMPLETED
- Phase
- PHASE4
Dose Individualization of Pemetrexed - IMPROVE-III
- Status
- COMPLETED
- Phase
- PHASE4
Dose Individualization of Pemetrexed - IMPROVE-II
- Status
- TERMINATED
- Phase
- PHASE4
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE2
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
DENdritic Cell Immunotherapy for Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM
- Status
- COMPLETED
- Phase
- PHASE2
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2